SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 03, 13:20
1309.30
-0.3 (-0.02%)
VOLUME 63,551
LIVE
NSE
Sep 03, 13:20
1309.35
0.75 (0.06%)
VOLUME 260,879
News on Lupin
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
12 Indian firms in Forbes' 50 best cos in Asia Pacific

4.14 pm | 02 Sep 2014 |  Source: PTI

TCS, HCL Tech and HDFC Bank are among the 50 best public companies in Asia-Pacific according to a compilation by Forbes, which ranked India second beh...

Buy HPCL, Lupin, Maruti Suzuki: Sudarshan Sukhani 

2.44 pm | 28 Aug 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Hindustan Petroleum Corporation, Lupin and Maruti Suzuki India....

Here are top 10 stocks to focus on August 28 

8.38 am | 28 Aug 2014 |  Source: CNBC-TV18

Here are top 10 stocks to focus on August 28 - HDFC, Lupin, DLF, MCX, Adani Power, UPL, Kalindee Rail, Nitesh Estates, Piramal Enterprises and TV Toda...

Logic behind big bang spike in pharma stocks

3.25 pm | 26 Aug 2014 |  Source: Moneycontrol.com

According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high lo...

Prefer Infosys, Tech Mahindra, Hexaware: CK Narayan 

10.56 am | 26 Aug 2014 |  Source: CNBC-TV18

According to CK Narayan, MD of Growth Avenues, one may prefer Infosys, Tech Mahindra and Hexaware Technologies from IT space....

See Nifty support at 7840; like Infy, Lupin: Growth Avenues 

9.38 am | 26 Aug 2014 |  Source: CNBC-TV18

CK Narayan, managing director of Growth Avenues believes investors will now move to traditional defensives of IT and pharma. In the IT space, he likes...

Can Indian pharma sector lead the bull run from hereon?

4.01 pm | 25 Aug 2014 |  Source: Moneycontrol.com

The S&P Healthcare index is up nearly 32 percent this year, compared to 25 percent rally on the stock exchanges benchmark 30-share index Sensex. ...

Buy Sun Pharmaceuticals, Lupin: Sandeep Shah 

4.11 pm | 23 Aug 2014 |  Source: CNBC-TV18

According to Sandeep Shah of Motilal Oswal Private Wealth Management, one may buy Sun Pharmaceuticals and Lupin....

Checkout: Religare Capital's top pharma bets 

3.35 pm | 21 Aug 2014 |  Source: CNBC-TV18

Arvind Bothra picks Aurobindo Pharma as his favourite bet among midcaps and Sun Pharma and Lupin among large caps....

Shasun Pharma may go to Rs 215-220: Ambareesh Baliga 

10.15 am | 21 Aug 2014 |  Source: CNBC-TV18

Market expert, Ambareesh Baliga feels that Shasun Pharmaceuticals may go to Rs 215-220 where one should book out completely....

Prefer Sun Pharma, Lupin: Tirthankar Patnaik 

1.16 pm | 14 Aug 2014 |  Source: CNBC-TV18

Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets prefers Sun Pharmaceutical Industries and Lupin from the pharmaceuti...

Buy Lupin 1180 Call, says VK Sharma 

11.45 am | 14 Aug 2014 |  Source: CNBC-TV18

VK Sharma of HDFC Securities is of the view that one may buy Lupin 1180 Call....

See Nifty at 8000 by Dec; bullish cement, pharma: Religare 

10.22 am | 14 Aug 2014 |  Source: CNBC-TV18

Patnaik feels a further reduction in monetary stimulus in the US will trigger a knee jerk reaction in emerging markets...

Why capex of top 20 Indian pharma firms is set to jump 40%

3.05 pm | 13 Aug 2014 |  Source: Moneycontrol.com

Out of this lot of 20, the capex spending of 8 companies – which currently generate a majority of revenues domestically – will almost double by fi...

Mkt undertone buoyant; like Lupin, Infy, avoid BHEL: Emkay 

11.47 am | 13 Aug 2014 |  Source: CNBC-TV18

Sachin Shah, fund manager at Emkay Investment Managers says the undertone of the market continues to be buoyant, with positive net flows and a fairly ...

Sun Pharma long term buy: Gopi Suvanam 

11.23 am | 13 Aug 2014 |  Source: CNBC-TV18

According to Gopi Suvanam of InvestWorks, Sun Pharmaceutical Industries is a long term buy and feels that one may build position in Cipla....

Investors likely to favour China; see rate hikes in US: F&C 

10.51 am | 12 Aug 2014 |  Source: CNBC-TV18

Chowdhry says the the recent Union Budget was a tad disappointing and that policy decisions will take time to come through...

Hold Lupin; target of Rs 1289: ICICIdirect

4.32 pm | 07 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com has recommended hold rating on Lupin with a target price of Rs 1289, in its research report dated July 31, 2014....

Lupin inks pact with S Korean firm to launch diabetes drug

2.30 pm | 06 Aug 2014 |  Source: PTI

As per the strategic distribution pact inked between the two companies, Mumbai-based Lupin will launch LG Life Sciences' Insulin Glargine, a novel ins...

Lupin launches Basugine

1.59 pm | 06 Aug 2014 |  Source: Moneycontrol.com

Lupin today announced a strategic distribution agreement with LG Life Sciences to launch insulin Glargine under the brand name Basugine....

1 2 3 4 5 6
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.